I-Bone Mineral Density Medication
Evista - Kuyini nokuthi Kuyini
Uma une-osteoporosis noma i-osteopenia, noma u-post-menopausal futhi engozini enkulu yokuba nomdlavuza webele we-invasive, udokotela wakho angase anikeze u-Evista.
I-Evista yigama le-raloxifene.
Ekhiqizwa ngu-Eli Lilly Corporation, u-Evista ukwandisa ubukhulu bamathambo akho. Yenza umsebenzi wayo ngokulingisa imiphumela ye-estrogen, i-hormone, phakathi kwezinye izinto, eyakha izicubu zethambo.
Futhi ngenxa yokuvimbela umdlavuza webele we-invasive, i-Evista ivimbela umphumela we-estrogen emathisini asebele - njengoba i-estrogen eningi emzimbeni ingafaka ingozi yalesi sifo.
Qaphela ukuthi i-Evista yenzelwe abesifazane base-postmenopausal , okusho ukuthi uma ukhulelwe, uhlengikazi noma usakwazi ukukhulelwa, kungcono ukukhuluma nodokotela wakho ukuthi ngabe lo muthi ulungile yini kuwe.
I-Evista - I-Class Medicine
I-Evista, (igama elivamile: i-raloxifene) yi- SERM , emele ama-modulator e-estergen receptor. Ama-SERM amakhemikhali okwenza izinto eziphazamisa amasayithi ezithombeni zomzimba (okuthiwa yi "receptors") ngokuvamile evame ukuthola ama-molecule e-estrogen. Kuye ngezicubu, ama-SERM angakwazi ukuvimba noma ukuthuthukisa imiphumela ye-estrogen.
I-Evista Side Effects
Kodwa ama-SERM, kuhlanganise ne-Evista, angakuthinta ngezindlela ezingafuneki, futhi. (Lokhu kuzoba nemiphumela emibi.) Nakuba ama-SERM akwazi ukulinganisa i-estrogen ukuze kusize ukuthuthukisa ezinye izicubu zethambo, noma uvimbele imiphumela ye-estrogen emathanjeni esifuba ukusiza ukuvimbela umdlavuza webele we-invasive, ukuwathatha nakho kungaholela emagqabeni omlenze, ukukhanya okushisayo , ikhanda, isizungu, ubuhlungu obuhlangene, ukuhlanza kanye / noma izinkinga zesinasi.
Futhi lezi ziyizinhle nje. Imiphumela emibi kakhulu ingenzeka. Uma uhlangabezana nanoma yikuphi kwalokhu okulandelayo, ochwepheshe kwi-website ye-Emedicine bathisa ukufuna ukunakekelwa kwezempilo ngokushesha:
- Izibonakaliso zokuphendula okweqile, isibonelo isifuba, ukuphefumula ubunzima kanye / noma ukuvuvukala kwezindebe zakho, ubuso, ulimi noma umphimbo.
- Kwenzeka kungazelelwe:
- Ubumbulu noma ubuthakathaka, ikakhulukazi kolunye uhlangothi lomzimba
- Inhloko, ukudideka, izinkinga nombono wakho, inkulumo, noma ibhalansi
- Ubuhlungu besifuba, ukukhwehlela, ukuqhuma, ukuphefumula okusheshayo kanye / noma ukushaya kwenhliziyo okusheshayo
- Ukuvuvukala ezandleni noma ezinyaweni zakho
- Izimpawu ezinjenge-Flu: Imfiva, izikhukhula, umphimbo nobuhlungu bomzimba
- Ukusuka kwamagciwane, ubuhlungu besisu noma ububele. Isibungu esiswini sakho siphinde sikhathazeke.
- Ukuvuthwa okubuhlungu, kuhlanganise nokuzwa okuvuthayo
- Ubuhlungu obukhulu obuphansi emuva.
Ukusebenzisana kwezidakamizwa
Ngaphambi kokuba uqale u-Evista, kubaluleke kakhulu ukutshela udokotela wakho nganoma yiziphi izidakamizwa osuvele uthatha. Isizathu ukuthi ezinye izidakamizwa azihlanganisi no-Evista, isibonelo i-cholestyramine (amagama omngqamuzana we-Prevalite ne-Questran), okuyisidakamizwa esinciphisa i-cholesterol.
Abanqamuki begazi, njenge-Warfarin noma i-Coumarin bangase bakhiphe inkinga, futhi. (Udokotela wakho angalawula ukuhlola okuhlola i-prothombrin ukuqinisekisa ukuthi izidakamizwa ezimbili ezihlanganisiwe zizokuphepha kuwe.)
Futhi, u-Eli Lilly uxwayisa ukuba ungathathi u-Evista uma uthola ukwelashwa kwe-estrogen ekhishwa ngepilisi, patch noma ngomjovo.
Ezinye izidakamizwa ezingase zihlangane no-Evista zifaka i-Valium (igama elivamile elithi diazepam,) ne-Proglycem (igama elivamile elithi diazoxide.) Ne- ibuprofen .
Izimo ezithile zezokwelapha nemikhuba yokuphila azihlangani kahle no-Evista. Okokuqala futhi okubaluleke kakhulu, uma une-allergic ku-raloxifene, kufanele uhlale kude no-Evista.
Okufanayo nokho uma ubhema, uye waba ne-blood clot, unesifo senhliziyo, isifo segazi esiphakeme, isifo sezinso, isifo sesibindi, uye waba nezinhlangothi (ngisho ne-TIAs ukubalwa lapha), noma uma unesifuba umdlavuza ngaphambilini.
Qaphela ukuthi uhlu olungenhla lwezidakamizwa, izimo nemikhuba yokuphila ayiphelele. Khuluma nodokotela wakho ukuze uthole lonke ulwazi.
> Imithombo:
> RxList. I-Pharmacie Pharmacology - Ukwamukelwa 12.08.04. Ibuyiselwe ngoJulayi 31, 2006.
> RxList. I-Pharmacology Pharmacology - Indlela Yokusebenza 12.08.04. Ibuyiselwe ngoJulayi 31, 2006
> Imithi kanye nezidakamizwa. Emedicine. Kufinyelelwe: Okthoba 2016. http://www.emedicinehealth.com/drug-raloxifene_oral/article_em.htm
> RxList. Imiphumela emibi 12.08.04. Ibuyiselwe ngoJulayi 31, 2006.
I-Evista, (igama elivamile: i-raloxifene) yi- SERM , emele ama-modulator e-estergen receptor. Ama-SERM amakhemikhali ahlanganiswayo ahlanganisa i-INTERFERE WITH amasayithi emzimbeni womzimba wakho (obizwa ngokuthi "receptors") ngokuvamile evame ukuthola ama-molerote e-estrogen. UKUSEBENZA NGOKWESIFUNDO SOKUSEBENZA, I-SERMS IYAVELA UKUHLOLA KANYE NOKUTHUTHUKISWA KWE-ESTROGEN. "Empeleni, i-SERM ihlala noma ishintshe i-estrogen, futhi ngenxa yalokhu, ingashintsha umzimba wakho ngezindlela ezichazwe ngenhla. (Ukunemba)